Clinics in Orthopedic Surgery • Vol. 11, No. 1, 2019 • www.ecios.org led to improvements in 62% of patients during an early follow-up and 20% of patients during a long-term followup.
Many studies, including the one by Donovan et al., 8) reported that facet joint lesions are associated with axial pain of the thoracolumbar area and referred pain to the limbs. This referred pain can have varying effects on patients with identical locations of lesions and even varying effects on one individual at different times of the day, which can cause diagnostic confusion. Generally, thorough history taking and recognition of symptoms are required for the differential diagnosis. However, Laplante et al. 9) stated that discogenic, facet joint, and sacroiliac joint pain, which mediate lumbar pain, are related to overlapping pain, i.e., radiating pain to the lower legs. Multivariate analysis could not differentiate the etiology based on the presence of radiating pain to the lower legs. Physical examination and imaging studies can be useful, but it remains difficult to confirm the diagnosis because the characteristics of pain cannot be easily identified clinically.
In practice, buttock pain is very common, and there is no set guideline for its diagnosis and treatment. In the past, studies have investigated lower leg radiating pain or lumbar pain, but no study has investigated the etiology of buttock pain or its treatment.
This article attempted to make a retrograde inference of the etiology of pain by comparing the treatment outcome of patients with buttock pain receiving different types of nerve blocks. If buttock pain is improved after selective nerve root blocks, then the pain is likely to be caused by radiculopathy. If the pain is relieved by facet joint blocks, then the pain is likely to be caused by degenerated facet joints.
METHODS

Patients
This prospective study targeted 191 patients with buttock pain who visited Kosin University Gospel Hospital from June 2017 to September 2017, with at least 3 weeks of Quebec Task Force category I or II pain, and who could be followed up for more than 3 months. Imaging tests using X-ray and magnetic resonance imaging (MRI) were conducted in all patients of this article. Patients in this research only had buttock pain and no radiating pain. Either a selective nerve root block (group A) or a facet joint block (group B) was conducted on patients with lumbar central canal stenosis grade 2 or above and patients with lumbar foraminal stenosis grade 2 or above. 10, 11) Exclusion criteria were as follows: patients with a single herniated nucleus pulposus with concurrent symptoms with dermatome and myotome involvement confirmed by MRI, those with sagittal spinal imbalance of more than 10 cm in front of the posterosuperior corner of the S1 vertebral body from the C7 plumb line, those with an acute fracture, those with paralysis, and those with a prominent hip joint lesion on physical examination and imaging studies. In total, 146 patients met the study inclusion criteria; 76 patients who were treated with the selective nerve root block were assigned to group A, and 70 patients who were treated with the facet joint block were assigned to group B.
Study Interventions
The blocks were performed by a single skilled physician (CSK). The location of the facet joint block was selected based on local tender points and the tender points identified by the patient. When local tenderness was prominent, the physician determined the injection point based on the severity of tenderness and the laterality of the pain. After the joint was selected, patients were placed in the prone position with a pillow underneath the abdomen, thus inducing kyphosis of the lumbar spine. With a posterior approach, the articular processes were widened, sterilized according to routine procedures, and evaluated under fluorescent light. Local anesthetic with 1% lidocaine was performed. Then, injection was performed using a 22-25-G needle at the inferior articular process of the facet joint. A tenderness provocation test was performed using 1-3 mL of a non-neurotoxic contrast (water-soluble contrast media; Telebrix, Schering, Berlin-Wedding, Germany). Anterior-posterior and lateral plain radiographs were obtained to identify the shape of the joint. Then, 0.5 mL of lidocaine and 1 mL of dexamethasone were injected into the joint. When multiple joints were treated, the amount of dexamethasone was the same, and 1 mL of lidocaine was mixed per joint. No more than three vertebrae were treated with injection at the same time.
Nerve root blocks were performed at the prospective spinal root lesion assisted by the use of plain radiographs, computed tomography, or MRI. In principle, one spinal nerve root was treated during each session, but when the symptoms were present bilaterally, two treatments were provided during the same session. The vertebral nerve root block was performed using the posterior approach. The patient was placed in a prone position on the radiation table and treated with local anesthesia. Using fluoroscopy, a 22-G spinal needle was inserted from a point located 4 cm lateral to the superior lumbar spinous process to a point located on the lateral side of the vertebral body and the inferior transverse process at 30°-45° angle from the sagittal plain caudally so that the needle passed through the entrance of the intervertebral foramen. However, in case of S1 nerve root block, because of the anatomical structure of the sacrum, the needle was inserted slowly into the first sacral foramina at an approximately 10°-15° oblique angle in the caudal direction in order to reach the first sacral nerve. When the end of the needle stimulated the nerve root, the patient would feel a sharp radiating pain or numbness. At this point, 0.5 mL of water-soluble contrast media (Telebrix) was injected to identify the traction of the nerve root, and a mixture of 0.5 mL of dexamethasone and 0.5 mL of lidocaine was injected. After the selective nerve root block, bed rest for 3 hours was prescribed until the resolution of numbness, desensitization, and asthenia.
In order to prevent infection during the treatment, all procedures were performed as aseptically as possible. Patients who were older in age or with lowered immune function were treated with additional caution. Treatment for iatrogenic infection was planned in advance.
Outcome Measures and Statistical Analysis
Evaluation was performed before the procedure and on post-procedure day 1, week 2, week 6, and week 12 using the visual analog scale (VAS) and the Korean version of the Oswestry Disability Index (K-ODI) 2.0. The evaluation was performed according to the following scale: poor, VAS score improved by less than 1 point; fair, VAS score improved by 1-2 points; good, VAS score improved by 3-4 points; and excellent, VAS score improved by greater than 5 points. Then, the results were compared according to the method of injection.
Statistical analysis was performed using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA), and the control values were compared using the t-test. All values are reported as a mean and standard deviation. Because of the limited number of patients, the results did not follow a chi-square distribution; thus, 2 × 2 cross-table analysis was performed using Fisher exact test to analyze the response to injection.
RESULTS
In group A, 28 patients were male and 48 were female. Patients' mean age was 65 years (range, 34 to 87 years), and the mean follow-up period was 5.3 months. In group B, 27 patients were male and 43 were female. Patients' mean age was 65 years (range, 35 to 85 years), and the mean followup period was 5.5 months. There was no significant difference between groups in terms of sex, age, or underlying diseases (Table 1) .
One day after the procedure, an excellent response was found in 7% of group A and in 6% of group B, and a good response was found in 41% of group A and in 13% of group B. Two weeks after the procedure, an excellent response was found in 11% of group A and in 4% of group B, and a good response was found in 41% of group A and in 20% of group B. Six weeks after the procedure, an excellent response was found in 11% of group A and in 7% of group B, and a good response was found in 41% of group A and in 20% of group B. At the final follow-up, 12 weeks after the procedure, 47% showed a good response in group A, and 46% showed a good response in group B (Fig. 1) . In group A, VAS improved compared to the preprocedure value of 5.01 to 2.74 on day 1, 2.51 at week 2, 2.38 at week 6, and 2.39 at week 12. In group B, the VAS score improved compared to the pre-procedure value of 5.24 to 3.94 on day 1, 3.99 at week 2, 3.24 at week 6, and 2.59 at week 12. On day 1 and at weeks 2 and 6, group A showed a significantly better outcome than group B (p < 0.05) ( Table 2) .
In group A, K-ODI improved compared to the preprocedure value of 34.03 ± 5.42 to 15.68 ± 3.00 on day 1, 15.21 ± 2.28 at week 2, 16.11 ± 2.69 at week 6, and 17.08 ± 3.31 at week 12. In group B, K-ODI showed a trend toward improvement compared to the pre-procedure value of 34.65 ± 5.28 to 17.66 ± 3.54 on day 1, 17.94 ± 3.21 at week 2, 18.49 ± 3.29 at week 6, and 18.43 ± 3.26 at week 12. On day 1 and at weeks 2 and 6, group A showed significantly better outcome in terms of symptom relief than group B (p < 0.05) ( Table 3) .
DISCUSSION
Macnab and MacCulloch 12) categorized degenerative diseases of the spine according to the etiology of pain as psychogenic, viscerogenic, vascular, neurogenic, and spondylogenic. Degenerative diseases of the spine such as spinal stenosis, facet joint syndrome, lumbosacral arthritis, and hip joint-related disorders including greater trochanter syndrome, iliotibial band syndrome, hip osteoarthritis, and avascular necrosis can all cause buttock pain. Therefore, it is crucial to identify the underlying etiology of buttock pain. Patients with spinal stenosis more often present with buttock pain as a chief complaint rather than radiating pain to the legs. Additionally, patients with facet joint syndrome can have lumbar pain and buttock pain. However, it is unclear if buttock pain in degenerative spine disease is caused by spinal stenosis or facet joint syndrome. Mooney and Robertson 7) argued that the facet joint plays an important role in causing lumbar pain. Robinson et al. 13) questioned the effects of anti-inflammatory injection to the facet joint. Krempen et al. 1) reported that a nerve root block should be used for patients whose radiological evaluations cannot fully identify the cause of pain or differentiate the characteristic of pain as referred or radiating.
The facet joint is innervated by the medial branch of the dorsal ramus of the nerve originating from the superior segment and the corresponding segment; the nerve to the facet joint is a nociceptive receptor. Marks 14) reported that based on clinical facet joint injection, buttock pain usually originates at the L4-5 level. On the other hand, inguinal pain usually originates at the L2-5 level. The nerve that innervates the facet joint produces referred distal pain more prominently than joint pain itself. Mehta and Sluijter 15) argued that even if there is no evident degenerative change in the facet joint detected by radiography, a patient can have lumbar pain, and lumbar pain is generated from the capsule rather than the frame of the facet joint.
Radiating pain is mediated through the anterior primary ramus. Bernard and Kirkaldy-Willis 16) reported that radiating pain occurs at the waist, buttock, calf along the sciatic nerve, or the anterior thigh along the femoral nerve. Allegri et al. 17) also reported that inflammation plays a more important role than direct compression of the nerve 
